Stock listing
AMG Stock Price, News, Filings & Events — Amgen Inc.
Selected listing: AMG · SWB · EUR · DE
This page tracks Amgen Inc.'s AMG:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AMG:SWB. AMG:SWB is the stock-level entry point for investors researching Amgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Amgen Inc. is a leading biotechnology company based in the United States, focused on developing innovative therapies for serious illnesses. With a market capitalization of approximately $197.7 billion, Amgen is recognized for its commitment to advancing science and improving patient outcomes. The company operates in a dynamic market, continually working to address unmet medical needs through its research and development efforts.
- Ticker
- AMG:SWB
- Asset type
- Stock
- Market cap
- $208.49B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- SWB
- Currency
- EUR
Amgen Inc. AMG:SWB stock context
This page tracks Amgen Inc.'s AMG:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AMG:SWB. AMG:SWB is the stock-level entry point for investors researching Amgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Amgen Inc. is a leading biotechnology company based in the United States, focused on developing innovative therapies for serious illnesses. With a market capitalization of approximately $197.7 billion, Amgen is recognized for its commitment to advancing science and improving patient outcomes. The company operates in a dynamic market, continually working to address unmet medical needs through its research and development efforts.
Latest news from Amgen Inc.
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer
September 18, 2026
FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®
September 14, 2026
In the PAPILLON Study, First-Line Amivantamab-Chemotherapy Demonstrates the Longest Overall Survival Reported for EGFR Exon 20 Insertion-Positive Advanced NSCLC
September 14, 2026
Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial
September 13, 2026
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
September 9, 2026
Amgen Inc. earnings calls
Amgen Inc. (AMGN) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q4 2025 Earnings Call
February 3, 2026 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Amgen Inc.
Amgen Inc. investor report
Review AI stock analysis and investor report context for AMG:SWB.
Amgen Inc. company profile
View the public company page for Amgen Inc. on 6ix.
Amgen Inc. news
Read company news and market updates connected to Amgen Inc..
Amgen Inc. investor events
Find investor webinars, events, and replay context for Amgen Inc..
Alternate listings
AMGN:NASDAQ
US · USD
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMG:GETTEX
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMGN:BCBA
AR · ARS
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMG:XETR
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMGN06:SET
TH · THB
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMG:TRADEGATE
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMGN:TSX
CA · CAD
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMGN34:BMFBOVESPA
BR · BRL
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
867900:LSX
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMGN:NEO
CA · CAD
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMGND:BCBA
AR · USD
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.
AMGN:BMV
MX · MXN
Alternate listing for Amgen Inc.; the primary context on this page is AMG:SWB.